A prospective audit of the adherence to a new magnesium sulphate guideline for the neuroprotection of infants born less than 30 weeks' gestation
YH Tan, KM Groom - Australian and New Zealand Journal of …, 2015 - Wiley Online Library
Antenatal magnesium sulphate reduces the risk of cerebral palsy in babies born< 30 weeks'
gestation. A guideline for its use in women at imminent risk of preterm birth was …
gestation. A guideline for its use in women at imminent risk of preterm birth was …
No. 376-magnesium sulphate for fetal neuroprotection
LA Magee, DA De Silva, D Sawchuck, A Synnes… - Journal of Obstetrics and …, 2019 - Elsevier
Objective The objective is to provide guidelines for the use of antenatal magnesium sulphate
for fetal neuroprotection of the preterm infant. Options Antenatal magnesium sulphate …
for fetal neuroprotection of the preterm infant. Options Antenatal magnesium sulphate …
Feasibility of implementing magnesium sulphate for neuroprotection in a tertiary obstetric unit
LL Ow, A Kennedy, EA McCarthy… - Australian and New …, 2012 - Wiley Online Library
Background It is important to establish whether research recommendations regarding
magnesium sulphate for neuroprotection can be readily translated into clinical practice and …
magnesium sulphate for neuroprotection can be readily translated into clinical practice and …
Translating antenatal magnesium sulphate neuroprotection for infants born< 28 weeks' gestation into practice: a geographical cohort study
LW Doyle, AJ Spittle, JE Olsen, A Kwong… - Australian and New …, 2021 - Wiley Online Library
Background Magnesium sulphate was introduced for fetal neuroprotection in Australia in
2010. The aim of this study was to determine how often antenatal magnesium sulphate is …
2010. The aim of this study was to determine how often antenatal magnesium sulphate is …
Magnesium sulphate at 30 to 34 weeks' gestational age: neuroprotection trial (MAGENTA)-study protocol
CA Crowther, PF Middleton, D Wilkinson… - BMC pregnancy and …, 2013 - Springer
Background Magnesium sulphate is currently recommended for neuroprotection of preterm
infants for women at risk of preterm birth at less than 30 weeks' gestation, based on high …
infants for women at risk of preterm birth at less than 30 weeks' gestation, based on high …
Nonreceipt of antenatal magnesium sulphate for fetal neuroprotection at the Women's and Children's Hospital, Adelaide 2010–2013
K Siwicki, E Bain, T Bubner, P Ashwood… - Australian and New …, 2015 - Wiley Online Library
Background Australian and New Zealand clinical practice guidelines, endorsed by the
NHMRC in 2010, recommend administration of antenatal magnesium sulphate to women at …
NHMRC in 2010, recommend administration of antenatal magnesium sulphate to women at …
Survey on use of antenatal magnesium sulphate for fetal neuroprotection prior to preterm birth in Australia and New Zealand–Ongoing barriers and enablers
K Gatman, R May, C Crowther - Australian and New Zealand …, 2020 - Wiley Online Library
Background Clinical practice guidelines recommend the use of antenatal magnesium
sulphate for fetal neuroprotection before preterm birth at< 30 weeks' gestation. Aims This …
sulphate for fetal neuroprotection before preterm birth at< 30 weeks' gestation. Aims This …
Use of magnesium sulfate in preterm deliveries for neuroprotection of the neonate.
S Usman, L Foo, J Tay, PR Bennett… - Obstetrician & …, 2017 - search.ebscohost.com
Key content: The prevalence of preterm birth is increasing and owing to advances in
neonatal care, more infants are surviving. However, in parallel with this, the incidence of …
neonatal care, more infants are surviving. However, in parallel with this, the incidence of …
Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus
Background Magnesium sulphate is a common therapy in perinatal care. Its benefits when
given to women at risk of preterm birth for fetal neuroprotection (prevention of cerebral palsy …
given to women at risk of preterm birth for fetal neuroprotection (prevention of cerebral palsy …
[PDF][PDF] Update on the use of magnesium sulphate for fetal neuroprotection in preterm birth
The administration of magnesium sulphate to mothers at risk for preterm birth for fetal
neuroprotection has demonstrated to reduce the risk of cerebral palsy and gross motor …
neuroprotection has demonstrated to reduce the risk of cerebral palsy and gross motor …